Table 2. Hematopathological features of DLBCL-IV patients.
Patient No. |
Diagnostic materials |
Diagnostic sites and rate of intravascular invasion (%) | CD5 | CD10 | Bcl-2 | Bcl-6 | IRF4/ MUM-1 | CD29 | CD54 | Ki-67 (%) | PD-L1 score |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Biopsy Autopsy |
(Biopsy) Skin (40) (Autopsy) Lungs, pancreas, stomach, esophagus, large intestine, urinary bladder (100), liver, kidneys (80), spleen (50), bone marrow (<1) |
- | - | + | + | + | - | - | 85 | 0 |
2 | Surgery | Ovary (80) | - | - | + | - | + | - | + | 45 | 2 |
3 | Biopsy | Skin (70) | - | - | + | + | + | - | +/-* | 50 | 1 |
4 | Biopsy | Skin (100), bone marrow (<1) | + | - | + | - | + | - | - | NA | 0 |
5 | Biopsy | Skin (50), bone marrow (0) | + | - | - | + | + | + | - | 93 | 1 |
6 | Autopsy | Lungs, kidneys, adrenal glands, stomach (100), liver (85), spleen, bone marrow (0) | - | - | + | - | + | - | - | 75 | 0 |
7 | Autopsy | Lungs, liver, adrenal glands, stomach, pancreas, esophagus, small intestine, large intestine, lymph nodes (100), breast (10), bone marrow (0) |
- | + | + | + | + | - | - | 50 | 1 |
8 | Autopsy | Lungs, liver, adrenal glands, stomach, pancreas, esophagus, small intestine, large intestine, heart, gallbladder, urinary bladder, testis (100), kidney (85), lymph nodes (15), spleen, bone marrow (<1) |
+ | - | + | - | - | - | - | NA | 0 |
9 | Autopsy | Kidney, adrenal glands, stomach, heart, uterus (100), lungs (60), liver (20), lymph nodes (<1), spleen, bone marrow (0) |
+ | - | + | - | + | + | + | 50 | 2 |
10 | Autopsy | Kidney, stomach, pancreas, heart, gallbladder, small intestine, large intestine, urinary bladder, thyroid gland, uterus, fallopian tubes (100), ovaries (80), lungs, adrenal glands (70), liver (50), spleen, lymph nodes (<1), bone marrow (0) |
+ | - | + | + | + | - | + | 40 | 2 |
11 | Autopsy | Lungs, kidneys, stomach, urinary bladder, heart, thyroid gland, prostate, brain (100), adrenal glands (80), liver (50), lymph nodes (0) |
- | + | + | - | - | - | + | 70 | 0 |
Abbreviations: DLBCL-IV, diffuse large B-cell lymphoma with significant intravascular invasion; NA, not available; PD-L1, programmed death-ligand 1.
* The extravascular, but not intravascular, lymphoma cells were negative for CD54.